These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7578647)

  • 21. [Dexamethasone suppression test and unipolar-bipolar classification of depression].
    Ayuso Gutiérrez JL; García-Camba E; Cabranes JA; Almoguera MI
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(1):1-4. PubMed ID: 4025025
    [No Abstract]   [Full Text] [Related]  

  • 22. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone.
    Rupprecht R; Kornhuber J; Wodarz N; Lugauer J; Göbel C; Haack D; Beck G; Müller OA; Riederer P; Beckmann H
    Biol Psychiatry; 1991 Jun; 29(11):1099-109. PubMed ID: 1651773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enhanced suppression of cortisol after dexamethasone in borderline personality disorder. A pilot study].
    Carrasco JL; Diaz-Marsá M; Ignacio Pastrana J; Molina R; Brotons L; Horcajadas C
    Actas Esp Psiquiatr; 2003; 31(3):138-41. PubMed ID: 12772042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course.
    Weaver JU
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):719-21. PubMed ID: 11895210
    [No Abstract]   [Full Text] [Related]  

  • 26. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 28. The hypothalamic-pituitary-adrenal axis in alcoholics.
    de La Fuente JR; Rosenbaum AH; Morse RM; Niven RG; Abboud CF; Jiang NS; Schatzberg AF
    Alcohol Clin Exp Res; 1983; 7(1):35-7. PubMed ID: 6342446
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis.
    Seok JH; Kim LS; Hong N; Hong HJ; Kim SJ; Kang HJ; Jon DI
    Gen Hosp Psychiatry; 2010; 32(5):503-8. PubMed ID: 20851271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.
    Oguz Y; Oktenli C; Ozata M; Ozgurtas T; Sanisoglu Y; Yenicesu M; Vural A; Bulucu F; Kocar IH
    J Endocrinol Invest; 2003 Jul; 26(7):609-15. PubMed ID: 14594109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women.
    Duclos M; Marquez Pereira P; Barat P; Gatta B; Roger P
    Obes Res; 2005 Jul; 13(7):1157-66. PubMed ID: 16076984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression test in geriatric depression.
    Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE
    Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207
    [No Abstract]   [Full Text] [Related]  

  • 35. The relationship of dexamethasone suppression to psychological test variables.
    Danahy SA; Schwartz BD; Willard SG; Winstead DK
    J La State Med Soc; 1986 Jan; 138(1):38-43. PubMed ID: 3950587
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preliminary study of the dexamethasone suppression test in endogenous depression].
    Omori T; Denda K; Koyama T; Matsubara S; Yasuda M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH; Orr WW; Stevenson JM; Shane SR
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 39. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids.
    Duclos M; Gatta B; Corcuff JB; Rashedi M; Pehourcq F; Roger P
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):447-54. PubMed ID: 11678826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test in fibrositis.
    Hudson JI; Pliner LF; Hudson MS; Goldenberg DL; Melby JC
    Biol Psychiatry; 1984 Oct; 19(10):1489-93. PubMed ID: 6596128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.